Literature DB >> 21524168

T-cell receptor specificity of CD8(+) Tregs in allotransplantation.

Elodie Picarda1, Ignacio Anegon, Carole Guillonneau.   

Abstract

Recent studies in the field of CD8(+) Tregs have allowed a better identification and characterization of this subset of regulatory cells. Their key role in the regulation of allogeneic responses is now well established. To take full advantage of CD8(+) Treg cells in future therapeutic applications, a better knowledge is required, particularly concerning the contribution of the T-cell receptor (TCR) in cell function as well as the role and importance of its antigenic specificity. Here, we focused on the CD8(+)CD45RC(low) Tregs, which in rats induce an indefinite long-term allograft acceptance. We summarized recent findings on their interaction properties with antigen-presenting cells. Identification of the antigenic targets and TCR repertoire of CD8(+) Tregs will allow a better understanding of their recognition properties and will highlight the potential of such of specific population in cell-based treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21524168     DOI: 10.2217/imt.11.37

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


  7 in total

1.  MHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection.

Authors:  Elodie Picarda; Séverine Bézie; Vanessa Venturi; Klara Echasserieau; Emmanuel Mérieau; Aurélie Delhumeau; Karine Renaudin; Sophie Brouard; Karine Bernardeau; Ignacio Anegon; Carole Guillonneau
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

2.  Common and small molecules as the ultimate regulatory and effector mediators of antigen-specific transplantation reactions.

Authors:  Vladimir Holan; Magdalena Krulova
Journal:  World J Transplant       Date:  2013-12-24

3.  Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.

Authors:  Séverine Bézie; Béatrice Charreau; Nadège Vimond; Juliette Lasselin; Nathalie Gérard; Véronique Nerrière-Daguin; Frédérique Bellier-Waast; Franck Duteille; Ignacio Anegon; Carole Guillonneau
Journal:  Blood Adv       Date:  2019-11-26

4.  IL-34 is a Treg-specific cytokine and mediates transplant tolerance.

Authors:  Séverine Bézie; Elodie Picarda; Jason Ossart; Laurent Tesson; Claire Usal; Karine Renaudin; Ignacio Anegon; Carole Guillonneau
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

5.  Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF).

Authors:  Jiezuan Yang; Ping Yi; Li Wei; Zherong Xu; Yunbo Chen; Lingling Tang; Lanjuan Li
Journal:  J Transl Med       Date:  2012-09-15       Impact factor: 5.531

Review 6.  Future prospects for CD8+ regulatory T cells in immune tolerance.

Authors:  Léa Flippe; Séverine Bézie; Ignacio Anegon; Carole Guillonneau
Journal:  Immunol Rev       Date:  2019-10-08       Impact factor: 12.988

7.  Fibrinogen-like protein 2/fibroleukin induces long-term allograft survival in a rat model through regulatory B cells.

Authors:  Séverine Bézie; Elodie Picarda; Laurent Tesson; Karine Renaudin; Justine Durand; Séverine Ménoret; Emmanuel Mérieau; Elise Chiffoleau; Carole Guillonneau; Lise Caron; Ignacio Anegon
Journal:  PLoS One       Date:  2015-03-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.